High materiality7/10
BeOne Medicines price target raised to $415 from $407 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises ONC price target to $415 with current price around $351, signaling upside potential.
- Barclays raises ONC target to $415; price is $351.
Key facts
- 01
Target: $415
- 02
Posted price: $351
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.